New Delhi [India], February 24:Recognising water and sanitation as critical frontiers in the climate challenge, the Center for Water and Sanitation (CWAS) at CEPT Research and Development Foundation (CRDF), CEPT University, launched its guidebook "Moving Towards Climate-Resilient Water and S
Hyderabad (Telangana) [India], February 20: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India's leading integrated contract research, development and manufacturing organizations (CRDMOs), today announced plans to hire 700+ scientific, technical, and management professional
India's Contract Research, Development and Manufacturing Organisation (CRDMO) sector is poised for accelerated growth, supported by surging global pharma outsourcing, rising demand for complex modalities, and geopolitical supply-chain realignment, according to a report by Kotak Mutual Fund.
India's pharmaceutical exports are nearing the USD 30-billion mark, setting the stage for the next phase of industry innovation powered by Contract Research and Development Organisations (CRDMOs) and Global Capability Centers (GCCs), according to a new EY-Parthenon-OPPI report.
Hyderabad (Telangana) [India], November 11: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India's fastest-growing Contract Research, Development & Manufacturing Organizations (CRDMO), today announced plans to recruit 200 scientists in November 2025 to serve the growing deman
Nucelion Therapeutics Pvt Ltd, a newly established Hyderabad-based Contract Research, Development, and Manufacturing Organisation (CRDMO) focused on cell and gene therapies, announced its formal launch on Monday.
Hyderabad (Telangana) [India], October 28: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India's fastest growing Contract Research, Development, and Manufacturing Organizations (CRDMO), today announced the groundbreaking for a new CMC Process R&D Center at its integrated R&D
Hyderabad (Telangana) [India], September 19: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredie
India's contract research, development, and manufacturing organisation (CRDMO) sector is emerging as one of the most dynamic growth stories in the global pharmaceutical landscape. According to a recent Jefferies India report, the country's CRDMO, which has already reached revenues of around
Indian CRDMOs (Contract Research and Development and Manufacturing Organizations) are seeing growing interest from global pharmaceutical companies, according to a recent report by Jefferies.
In a significant development, the Housing and Urban Development Corporation (HUDCO) has extended a massive Rs 11,000 crore loan to the Capital Region Development Authority (CRDA) for the construction of Amaravathi, the state capital of Andhra Pradesh, said the official statement.
The Indian Contract Research, Development, and Manufacturing Organization (CRDMO) sector is expected to reach to USD 22 to USD 25 billion by 2035, according to a report by Boston Consulting Group (BCG) and Innovative Pharmaceutical Services Organization (IPSO).